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Adjacent disc degeneration after lumbar 
total disc replacement or non-operative 
treatment: A randomized study with 
eight-year follow-up 
Abstract 
Study design. Randomized controlled multicenter trial with eight-year follow-up. 
Objective. To assess the long-term development of adjacent disc degeneration (ADD) after 
lumbar total disc replacement (TDR) or non-operative treatment, and to analyze the 
association between ADD development and clinical outcome. 
Summary of background data. TDR was introduced as a motion-preserving alternative to 
spinal fusion, which has been reported to increase the risk of ADD. However, ADD may 
develop naturally regardless of any surgery, and no randomized study has assessed the long-
term development of ADD after TDR versus non-operative treatment. 
Methods. The study included 126 of the 173 patients with chronic low back pain (LBP) 
originally included in a randomized study comparing TDR with multidisciplinary 
rehabilitation. Magnetic resonance imaging (MRI) of the lumbar spine was performed before 
treatment and at eight-year follow-up. ADD was categorized as increased or not increased 
based on an evaluation of Modic changes, disc height reduction, disc contour, herniation size, 
nucleus pulposus signal and posterior high intensity zones. We used a χ2 test or a Fisher’s 
exact test to compare crude proportions, and multiple linear regressions to analyze the 
association between increased ADD (yes/no) and change in Oswestry Disability Index (ODI) 
from pre-treatment to follow-up. 




Results. ADD increased (for at least one ADD variable) in 23 of 57 patients (40%) treated 
non-operatively, and 29 of 69 patients (42%) treated with TDR (p=0.86). We found no 
significant associations between ADD increase and the change in ODI. 
Conclusions. Increased ADD occurred with similar frequency after TDR and after non-
operative treatment, and was not related to the clinical outcome at eight-year follow-up.  
Key words: Low back pain, total disc replacement, non-operative treatment, adjacent disc 
degeneration. 
 
Level of evidence: 1 
 
Key points:  
• No differences were observed between lumbar total disc replacement and non-operative 
treatment in the development of adjacent disc degeneration at eight-year follow-up. 
• No association was found between increased adjacent disc degeneration and the clinical 
outcome. 
• Larger studies with longer follow-up are warranted. 
 
Mini abstract:  
In this eight-year follow-up of a randomized multicenter study comparing lumbar total disc 
replacement with non-operative treatment, the development of adjacent disc degeneration did 
not differ between the treatment groups and was not related to clinical outcome. 
  





Concern about adjacent disc degeneration (ADD) following spinal fusion has contributed to 
the development and implementation of motion preserving alternatives such as lumbar total 
disc replacement (TDR) in the surgical treatment of low back pain (LBP) [1 2]. According to 
the literature, ADD is mainly influenced by aging and genetics [3], and may develop 
regardless of any surgery [1 4 5]. In a meta-analysis [6] of four randomized studies with a 
mean follow-up of 13 years after spinal fusion or non-operative treatment, ADD was more 
strongly related to aging than to fusion, but was not associated with the clinical outcome. In 
the only randomized study of ADD after TDR versus non-operative treatment [7], ADD was 
neither related to TDR nor the clinical outcome at two-year follow-up. The aim of the present 
study was to assess the long-term development of ADD after TDR or non-operative treatment, 
and to analyze the association between ADD development and the clinical outcome.  
Materials and Methods 
This is a randomized multicenter study with eight-year follow-up conducted at five university 
hospitals in Norway [8]. The eight-year follow-up was approved by the Norwegian Regional 
Ethical Committee South East C (2011/2177). The project was conducted in accordance with 
the Helsinki Declaration and the ICH-GCP guidelines and it was registered at 
www.clinicaltrial.gov under the identifier NCT01704677 before it commenced. Results are 
reported according to the CONSORT standard.  
Patients 
Inclusion criteria for the original randomized trial were age 25-55 years, LBP as the main 
symptom for at least one year, Oswestry Disability Index (ODI) score ≥ 30 and degenerative 
changes at the disc levels L4/L5 and/or L5/S1 on magnetic resonance imaging (MRI). For 
further details see Hellum et al [9]. The present study included patients available for both 




radiological and clinical examination at eight-year follow-up. Patients who had been operated 
with lumbar fusion during follow-up were excluded.  
Interventions 
Non-operative treatment 
The non-operative treatment consisted of modern multidisciplinary rehabilitation with a 
cognitive approach and supervised physical exercise over three to five weeks, according to 
Brox et al [10].  
TDR 
In the TDR procedure, the degenerative intervertebral discs L4/L5 and/or L5/S1 were 
removed and replaced with artificial discs (ProDisc II, Synthes Spine), as detailed previously 
[9].  
Clinical outcome 
Pain and disability were evaluated with the Norwegian version 2.0 of the ODI [11 12] (scores 
range from 0 to 100, with a lower score indicating less pain and disability). LBP was 
measured with a visual analogue scale (VAS) ranging from 0 (no pain) to 100 (worst pain 
imaginable). We also collected information on reoperations due to ADD.  
MRI evaluation 
MRI variables for evaluating ADD were analyzed at the nearest level above the implanted or 
degenerated index level, i.e. at L3/L4 or L4/L5. MRI performed before treatment and at eight-
year follow-up included (a) sagittal T2-weighted fast spin echo (FSE) and/or DRIVE images 
(FSE with 90° flip-back pulse); (b) sagittal T1-weighted spin echo or fast fluid-attenuated 
inversion-recovery images; and (c) axial images of the lower lumbar levels (T2-, T1- or 
proton density-weighted). All follow-up MRIs and > 90% of pre-treatment MRIs were from 
1.5 T units. Metal artefact reducing techniques [13] were used on 97% of follow-up MRIs and 
implied thin slices (3 mm) and increased pixel bandwidth (BW), echo train length (ETL) and 




number of excitations (NEX). These follow-up MRIs included (a) sagittal T2-weighted FSE 
images: repetition time (TR) / echo time (TE), 4480-5000 ms / 92-94 ms; matrix 448x448; 
BW 413; ETL 30; NEX 3, (b) sagittal T1-weighted FSE images: TR / TE, 549-610 ms / 8 ms; 
matrix 448x448; BW 698; ETL 7; NEX 4, and (c) axial T2-weighted FSE images: TR / TE, 
4201-5190 ms / 72-92 ms; matrix 320x320 or 512x512; BW 390-413; ETL 20; NEX 2-3. 
Pre-treatment and follow-up images were anonymized, presented together in random order 
and evaluated independently by two radiologists from different institutions who had more 
than 15 years of experience in spine imaging. The observers could not be blinded to treatment, 
but were blinded to clinical data. They rated changes in MRI findings by comparing eight-
year follow-up and pre-treatment images on a clinical picture archiving and communication 
system (PACS) unit.  
Six ADD variables were rated: Extent of Modic changes [14 15], disc height [16], disc 
contour [17], disc herniation size [17], nucleus pulposus signal [18] and posterior high 
intensity zone (HIZ) [19] (Table 1). Conclusive ADD ratings were based on both the 
observers’ independent ratings and consensus between them in every instance of disagreement 
(review and discussion of images and findings). The interobserver agreement on increased 
rating value (yes/no) from pre-treatment to follow-up was fair for disc contour (kappa 0.37, 
disagreement 21%, mean yes rate 21%) and mostly good for the five other ADD variables 
(kappa 0.60-0.76, disagreement 3-10%, mean yes rate of 27% for nucleus pulposus signal and 
otherwise 7-12%). [20]. 
Statistical analysis 
The primary outcome measure was increased ADD (yes/no), defined as increased rating value 
from pre-treatment to follow-up for at least one ADD variable, as in a previous report [7]. 
Possible rating values are defined in Table 1. Decreased ADD (yes/no) was defined as 
decreased rating value for at least one ADD variable. Unchanged ADD implied that all rating 




values were unchanged. Two patients who had an increased rating value for one ADD 
variable and a decreased rating value for a different ADD variable were both classified as 
having increased ADD. 
For each ADD variable, we compared changes in ratings between the treatment groups. We 
performed crude comparisons using a χ2 test or a Fisher’s exact test for categorical variables 
and an independent two-sided t test for continuous variables. Patients who were randomized 
to TDR but not operated were analyzed in the non-operative group, and patients randomized 
to rehabilitation who later received TDR were analyzed in the TDR group, according to as-
treated principles (Figure 1). 
In a sensitivity analysis, we compared the proportions of patients with overall increased ADD 
in each group after excluding patients randomized to rehabilitation who later received TDR.  
In order to analyze possible associations between increased ADD and the clinical outcome 
adjusted for possible confounders, we fitted a multiple linear regression model. In this model, 
we excluded those who were not treated according to randomization, since the treatments 
influence the clinical outcome. The model included ODI change from baseline to follow-up as 
the dependent variable and the following independent variables: Developed / increased extent 
of Modic changes (yes/no), disc height reduction (yes/no), disc contour worsening (yes/no), 
decreased nucleus pulposus signal (yes/no), developed HIZ (yes/no), age, gender and type of 
treatment (non-operative / TDR). Increased herniation size occurred in only one patient and 
was therefore not part of the regression model. The model fit was good, with normally 
distributed residuals. The results are presented as an estimate of beta with 95% confidence 
intervals (CI). We also performed a multiple logistic regression with the same independent 
variables as above and “a satisfactory symptom state” (ODI ≤ 22 points at follow-up) (yes/no) 
[21] as the dependent variable. A significance level of 5% was used for all analyses. All 




analyses were considered exploratory so no correction for multiple testing was done. All 
statistical analyses were performed using SPSS version 24.0. 
Post hoc analysis 
Post hoc, we analyzed the severity of ADD development based on the number of worsened 
ADD variables. We compared the proportions of patients from each treatment group with 
increased rating for none, one, two, three, four, five and six ADD variables. 
Results 
In the original TDR group, 77 of 86 patients received the TDR, 14 were not available for 
follow-up, four patients could not be analyzed since they were operated on with spinal fusion, 
and in one patient, the pre-treatment MRI was untraceable. Therefore, only 58 of the original 
TDR group could be included. In addition, we included 11 patients randomized to 
rehabilitation who crossed over and were treated with TDR (median time since surgery was 
74 (range 61-85) months). Consequently, 69 patients treated with TDR were analyzed. In the 
original rehabilitation group, 14 of 87 patients had been treated with TDR and five with spinal 
fusion, 15 were not available for follow-up and one patient had an untraceable pre-treatment 
MRI. Therefore, only 52 of the original rehabilitation group could be included in the analyses. 
In addition, we included five patients randomized to surgery who were not operated. Thus, 57 
patients treated non-operatively were analyzed (Figure 1). The two treatment groups had 
similar pre-treatment clinical, demographical and radiological characteristics (Table 2). The 
126 patients included in the present analyses had similar pre-treatment clinical, 
demographical and radiological characteristics, and similar outcome measures at eight-year 
follow-up, as did the 47 patients who could not be included (p ≥ 0.12 for all analyzed 
variables, data not shown). 




At eight-year follow-up, 23 patients (40%) in the non-operative group and 29 patients (42%) 
in the TDR group had increased ADD (p=0.86). The increase was due to developed / 
increased extent of Modic changes, development of HIZ, decreased nucleus pulposus signal 
and/or disc height, worsened disc contour, and/or increased herniation size (Figure 2, Table 
3). Three patients (5%) treated non-operatively versus two patients (3%) treated with TDR 
had decreased ADD (p=0.66). Regression of ADD was due to disappearance of HIZ in three 
patients, disappearance of Modic changes in one patient and regression of disc herniation in 
one patient. The change in rating from pre-treatment to eight-year follow-up did not differ 
significantly between the treatment groups for any of the ADD variables (Table 3).  
The sensitivity analysis confirmed our results. After exclusion of the 11 patients randomized 
to rehabilitation and treated with TDR, 23 patients (40%) in the non-operative group and 24 
patients (41%) in the TDR group had increased ADD (p=0.89).  
None of the patients who were originally treated non-operatively had been operated at the 
adjacent level. One patient treated with TDR at L5/S1 had been re-operated 17 months after 
the initial procedure with fusion from L4 to S1, thus fusing the adjacent level. 
In the multiple linear regression analysis of the association between increased ADD and the 
clinical outcome, the only variable that was significantly associated with change in ODI at 
follow-up was type of treatment (non-operative or TDR) (B=7.2, 95% CI 0.5-13.8, p=0.04). 
Therefore, we analyzed each treatment group separately. However, we did not find any 
significant association between increased rating in any ADD variable and change in ODI 
(R2=0.06 (p=0.85) in patients treated non-operatively and R2=0.10 (p=0.50) in patients treated 
with TDR). Multiple logistic regression analysis did not reveal any association between the 
increase in any ADD variable and ODI ≤ 22 points. 




Post hoc analysis 
The two treatment groups did not differ significantly in regards to the proportion of patients 
with increased rating value for one, two, three or four ADD variables (p=0.38) (Figure 3). 
Discussion 
This eight-year follow-up of the first randomized trial to compare TDR with non-operative 
treatment revealed no difference in ADD development between the treatment groups. This 
supports the theory that ADD development is part of the natural course of degeneration. 
Furthermore, the ADD development was not related to the clinical outcome.  
In each treatment group, a larger proportion of patients had increased ADD at the eight-year 
follow-up than at the two-year follow-up (40% versus 19% after non-operative treatment and 
42% versus 13% after TDR) [7].) A further increase is expected with longer follow-up. 
Reduced range of motion (ROM) in the prosthesis has previously been reported to be 
associated with an increased prevalence of ADD [22 23]. We did not measure ROM at eight-
year follow-up, but at two-year follow-up [24] segmental ROM was similar for an average 
disc prosthesis as for a degenerated index level disc. This may have contributed to similar 
ADD development in both treatment groups. 
In a previous review of ADD following back surgery, Harrop et al [25] found a large variation 
in the reported ADD (0-24 % of the patients 3 to 17 years after TDR). However, the included 
studies were heterogeneous and had major limitations. The large variation in ADD most likely 
reflects differences in patient characteristics (e.g. age), follow-up time and ADD assessment 
methods. Such methods were either not reported or included disc height, osteophyte formation 
or instability on flexion-extension images. The variation in ADD assessment makes it difficult 
to compare the proportions of patients with ADD increase, also between recent studies. Zigler 
et al [26] based ADD on disc height reduction, endplate sclerosis, osteophytes and 




spondylolisthesis on radiographs. They found increased ADD in 9% of patients five years 
after TDR. We found a much higher proportion (42%) with increased ADD at eight-year 
follow-up. The difference may partly be due to our use of MRI to detect changes not visible 
on radiographs (Table 3).  
Regardless of allocation, 91 patients in our cohort have been treated with TDR [8], of whom 
one (1%) has been re-operated with fusion including the adjacent segment. This is in 
agreement with other studies reporting re-operation due to ADD in 0-1% of patients after two 
to five years following TDR [27-29].  
We found no significant association between increased ADD and the clinical outcome at 
eight-year follow-up. This is in line with a previous report from Huang et al [22] and with the 
results of a recent cross-sectional analysis of long-term follow-up data from four randomized 
trials comparing non-operative treatment with fusion for chronic LBP [6].  
The main strength of this study is its original randomized design that allows for prospective 
comparison of ADD development after TDR with the course of ADD in patients treated non-
operatively. Other strengths are the public financing of the study, the long follow-up time, the 
metal artefact reducing MRI protocol, the MRI evaluation performed independently by 
experienced radiologists blinded to the clinical outcome and the direct comparison of post- 
and pre-treatment MRIs to assess changes in ADD. Such comparison can reduce overrating of 
changes due to ambiguous findings or small differences in MRI techniques and can improve 
agreement on changes in ratings [30]. In this study, the agreement was mostly good, despite 
instances where a low prevalence of change tended to reduce many of the kappa values. The 
conclusive combined ratings from both observers were likely to be even more reliable [31], 
reducing the chance of underestimating the MRI findings’ relationship to other variables [32]. 




We studied a broad range of separate ADD variables. There are several ways to describe 
ADD, and no gold standard exists. The commonly used Pfirrmann system [33] provides a 
single rating of disc degeneration based on the height, structure and signal of the disc, and the 
distinction of nucleus and annulus. This system does not separate disc signal from disc height, 
and it does not include disc contour/herniation or HIZ – nor Modic changes, which were 
related to clinical outcome after TDR in our cohort in both the short- [34] and long-term [35]. 
Similarly, as at 2-year follow-up [7], we accepted an increase in only one ADD variable as 
indicating increased ADD. We were thus able to detect even small increases and differences 
in ADD.  
The main limitations of the present study are its small sample size and that only 73% of the 
original sample could be included. This may call the generalizability of the results into 
question. 
A further limitation is the choice of an as-treated analysis as the main analysis, since not all 
patients were analyzed according to the original randomization. However, the analyzed 
treatment groups had similar pre-treatment clinical, demographical and radiological 
characteristics. Since 24% of the patients randomized to rehabilitation were treated surgically, 
and 10% of those randomized to TDR were not operated [8], we considered an intention-to-
treat analysis to be unsuitable for analyzing the influence of TDR on ADD.  
The 11 patients who crossed over from rehabilitation to TDR had a shorter observation time. 
This may have reduced the proportion with increased ADD in the TDR group, but results 
were unchanged in the sensitivity analysis excluding these 11 patients. 
The radiologists could not be blinded to the treatment group, which represents a possible 
observer bias. They were not blinded to post-treatment images when assessing pre-treatment 
images, and this may have influenced their pre-treatment ratings. Disc prostheses leave metal 




artefacts on the images close to the implant, but, according to previous reports [36-38], such 
metal artefacts barely affect the evaluation of the adjacent disc level, and the metal artefact 
reducing MRI protocol further reduced the extent of the artefacts (Figure 2). The artefacts 
might hide the caudal part of large Modic changes extending caudally from the upper adjacent 
level, but we could still assess change in the size of Modic changes in all patients in our study.  
The choice of the primary outcome variable may be debated. Increased ADD (yes/no) was a 
mainly qualitative variable. Only one of the six underlying ADD variables (disc height) was 
based on an actual measurement. Our study still provides more information than studies 
restricted to disc height measurement alone. By defining increase in ADD as a dichotomized 
variable, we did not use information on the degree of the increase. It is not clear how a 
variable reflecting the overall degree of increase in ADD can be constructed and weighted 
based on increases in different underlying variables (disc signal, disc contour, HIZ, etc.). 
However, we compared the number of increased ADD variables between groups in a post hoc 
analysis (Figure 3).  
Several disc prostheses with different mechanical and geometrical properties are in use [39]. 
Different prosthesis designs allow different ROM, and the prosthesis used in this trial is 
classified as semi-constrained [39]. The mobility in the treated level can affect the 
development of ADD [22 23], and the development of ADD may have been different if 
another prosthesis design had been used.  
In conclusion, the development of ADD at eight-year follow-up did not differ between non-
operative treatment and TDR, and was not related to the clinical outcome. Hence, TDR as 
performed in the present study does not seem to increase the long-term risk of developing 
ADD, and patients developing ADD do not seem to have a worse outcome. Our results are 
similar with a recent study with long-term follow-up after lumbar fusion compared to non-




operative treatment [6], suggesting that other factors than fusion or TDR are important for the 
development of ADD. 
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605 patients screened for eligibility 
86 allocated to TDR 
426 ineligible 
• 378 did not meet inclusion criteria 
• 48 declined to participate 
87 allocated to rehabilitation 
179 enrolled and randomized  
• 6 excluded shortly after randomi-
zation due to exclusion criteria *  
9 did not receive TDR **  
 
69 included in TDR group 
14 crossed over and received 
TDR  
3 lost to follow-up  
(lost contact)  
52 included in analysis at 8 year 58 included in analysis at 8 year 
Figure 1: Trial profile 
77 received TDR 
19 lost to follow-up 
• 6 lost contact 
• 8 did not consent to 8-year 
follow-up 
• 1 missing pre-treatment MRI 
• 4 reoperated with fusion 
 
11 included in analysis at 8 year 5 included in analysis at 8 year 
4 lost to follow-up 
• 2 lost contact 
• 1 did not consent to 8-
year follow-up 
• 1 operated with fusion 
 
73 did not cross over to TDR  
 
21 lost to follow-up 
• 8 lost contact 
• 1 died (cancer) 
• 6 did not consent to 8-year 
follow-up 
• 1 missing pre-treatment MRI 
• 5 operated with fusion 
 
57 included in non-operative group 
*Included and randomized mistakenly, but excluded before intervention because of obvious exclusion criteria 

















Figure 2. Increased degeneration of the adjacent disc from baseline to eight-year follow-up 
after non-operative treatment (1-2) and total disc replacement (3-4).  
 
A=Modic changes, B=changed signal intensity of the disc and C=reduced disc height. 
Figure 3. Proportions of patients with different numbers of variables showing increased 
adjacent disc degeneration. 
 
 
Proportions of patients treated non-operatively or with total disc replacement with increased 
degeneration in the adjacent disc in none, one, two, three or four out of six variables (Modic 
changes, disc height, disc contour, herniation size, nucleus pulposus signal and posterior high 
intensity zone) were not significantly different (p=0.38). 
Table 1. The MRI variables that the evaluation of adjacent disc degeneration was based on. 
Variable Description Grading Reference 
Type of Modic 
changes 
Modic changes in the vertebral body marrow 
adjacent to the endplate. 
0: No change 
Type 1: Hypointense T1-signal and hyperintense T2-signal 
Type 2: Hyperintense T1-signal and iso- or hyperintense T2-signal 





The maximal craniocaudal extent of Modic 
changes. Vertebral body height was assessed on 
the image showing the largest height of Modic 
changes. 
0: No signal changes 
1: < ¼ of the vertebral body height 
2: ¼-½ of the vertebral body height 
3: > ½ of the vertebral body height 
Jensen 
2007 (15) 
Disc height The distance between the mid-inferior and the 
mid-superior disc borders, measured in 
millimetres on the mid-sagittal T2-weighted 
image. 
0: No change 






Disc contour The shape of the disc. 0: Normal 
1: Bulging (> 1/4 of disc circumference) 





Herniation size compared to the cross-sectional 
area of the spinal canal on axial view. 
0: No herniation 
1: <1/3 of cross-sectional area of the spinal canal 
2: 1/3-2/3 of cross-sectional area of the spinal canal 





Visually graded on sagittal T2-weighted images, 










An area of high-signal intensity in the posterior 
annulus fibrosus, brighter than or equally as bright 
as cerebrospinal fluid on sagittal T2-weighted 
images, and surrounded superiorly, inferiorly and 
anteriorly by the low-intensity signal of the 
annulus fibrosus. 








* The smallest detectable change in disc height has previously been calculated as 2 mm (Hellum 2006 (7)). Thus, disc height reduction < 2 mm from pre-
treatment to follow-up was rated as «no change». 
Table 2: Pre-treatment clinical, demographical and radiological characteristics in patients 
treated non-operatively (n=57) or operated with total disc replacement (n=69). 
 
* ODI=Oswestry Disability Index (0 to 100, lower scores indicate less severe symptoms) 
** VAS=Visual Analogue Scale (Calculated using a horizontal scale ranging from 0 (no pain) to 100 
(worst pain imaginable), with word anchors at the beginning and end). 
*** All radiological variables are measured by MRI at the upper adjacent level, except pelvic 
incidence, which is measured on plain radiograph with a lateral view of the patient in standing 
position. 
§ Luoma et al. (18) 
 No prosthesis  Missing Prosthesis  Missing p 
Clinical / demographical variables      
Age (median, range)  43 (29-54) 0 40 (25-54) 0 0.30 
Gender (female) (n, %) 33 (58) 0 33 (48) 0 0.29 
Comorbidity (n, %) 12 (21) 0 15 (22) 0 1.00 
Body mass index (median, range) 25.7 (19.7-33.2) 0 25.0 (18.5-35.4) 1 0.30 
Current smoker (n, %) 23 (40) 0 30 (44) 1 0.72 
Previous surgery (n, %) 15 (26) 0 21 (30) 0 0.69 
Index level  59 0 69 0 0.16 
  L4/L5 (n, %) 10 (18)  13 (19)   
  L5/S1 (n, %) 37 (63)  33 (48)   
  L4/L5 and L5/S1 (n, %) 11 (19)  23 (33)   
ODI* (median, range) 42 (30-66) 0 40 (28-68) 0 0.77 
Back pain (VAS**) (median, range) 73 (50-98) 2 70 (19-97) 2 0.09 
Radiological variables ***      
Pelvic incidence (median, range) 50 (33-71) 3 50 (25-75) 2 0.71 
Modic changes  57 0 69 0 0.96 
  Not present (n, %) 53 (93)  65 (94)   
  Type 1 (n, %) 1 (2)  1 (1)   
  Type 2 (n, %) 3 (5)  3 (4)   
Adjacent disc height (mm) (median, 
range) 
10 (6-14) 0 10 (8-14) 0 0.63 
Disc contour 57 0 69 0 0.16 
  Normal (n, %) 39 (68)  57 (83)   
  Bulge (n, %) 12 (21)  9 (13)   
  Herniation (n, %) 6 (11)  3 (4)   
Nucleus pulposus signal § 57 0 69 0 0.58 
  Bright (n, %) 25 (44)  35 (51)   
  Grey (n, %) 20 (35)  24 (35)   
  Dark (n, %) 12 (21)  10 (14)   
Posterior high intensity zone (n, %) 3 (5) 0 4 (6) 0 0.90 
Table 3: Radiological measures at adjacent discs L3/L4 or L4/L5 before treatment and at eight-year follow-up in 57 patients treated non-operatively and 69 
patients with total disc replacement. 
 
 
* p values (Pearson Chi-Square test for differences in changes for the worse when comparing the two groups) 
** Luoma et al. (18) 










Modic changes  57 57  69 69  0.98 
  Not present (n, %) 53 (93) 48 (84) -5 65 (94) 59 (86) -6  
  Type 1 (n, %) 1 (2) 1 (2) 0 1 (1) 6 (9) +5  
  Type 2 (n, %) 3 (5) 7 (12) +4 3 (4) 4 (6) +1  
  Both type 1 and 2 (n, %) 0 1 (2) +1 0 0 0  
Maximal craniocaudal extension of Modic changes (n, %) 57 57  69 69  0.94 
  No Modic changes 53 (93) 48 (84) -5 65 (94) 60 (8) -5  
  < ¼ of vertebral body height  1 (2) 4 (7) +3 2 (3) 1 (1) -1  
  ¼ - ½ of vertebral body height 2 (4) 4 (7) +2 1 (1) 4 (6) +3  
  > ½ of vertebral body height 1 (1) 1(1) 0 1 (1) 4 (6) +3  













Adjacent disc height reduction ≥ 2 mm from pretreatment to 
long-term follow-up (n, %) 
 3 (5)   11 (16)  0.09 
Disc contour 57 57  69 69  0.53 
  Normal (n, %) 39 (68) 28 (49) -11 57 (83) 41 (59) -16  
  Bulge (n, %) 12 (21) 18 (32) +6 9 (13) 20 (29) +11  
  Herniation (n, %) 6 (11) 11 (19) +5 3 (4) 8 (12) +5  
Herniation size 57 57  69 69  0.38 
  < 1/3 of spinal canal 6 (11) 10 (18) +4 3 (4) 6 (9) +3  
  1/3-2/3 of spinal canal 0 1 (2) +1 0 2 (3) +2  
  > 2/3 of spinal canal 0 0 0 0 0 0  
Nucleus pulposus signal ** 57 57  69 69  0.68 
  Bright (n, %) 25 (44) 20 (35) -5 35 (51) 22 (32) -13  
  Grey (n, %) 20 (35) 18 (32) -2 24 (35) 30 (43) +6  
  Dark (n, %) 12 (21) 19 (33) +7 10 (14) 17 (25) +7  
Posterior high intensity zone (n, %) 3 (5) 5 (9) +2 4 (6) 5 (7) +1 0.45 
